All Comments by Elliott Mufson

  1. Controlling amyloid beta-peptide fibril formation with protease-stable ligands.
  2. Zinc and Alzheimer's disease: is there a direct link?
  3. Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor.
  4. Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer's disease.
  5. Choline acetyltransferase mRNA expression in the striatal neurons of patients with Alzheimer's disease.
  6. Weight, blood pressure, osmolarity, and glucose levels across various stages of Alzheimer's disease and vascular dementia.
  7. Heparin promotes beta-secretase cleavage of the Alzheimer's amyloid precursor protein.
  8. A computational model of the progression of Alzheimer's disease.
  9. Aluminum concentrations in drinking water and risk of Alzheimer's disease.
  10. The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease.
  11. Gender-specific nonrandom association between the alpha 1-antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease.
  12. Apolipoprotein E and Alzheimer's disease: a review of recent studies.
  13. Down syndrome.
  14. Educational level and neuropsychological heterogeneity in dementia of the Alzheimer type.
  15. Psychiatric correlates of MR deep white matter lesions in probable Alzheimer's disease.